ATM and the DNA damage response

The 2005 International Workshop on Ataxia‐Telangiectasia, ATM and the DNA Damage Response took place between 8 and 11 June 2005 on the banks of Lake Maggiore, Italy. The workshop was organized by L. Chessa and D. Delia. ![][1] This workshop on ataxia‐telangiectasia marked the tenth anniversary of the discovery of the gene that is defective in this syndrome—that is, ataxia‐telangiectasia mutated ( ATM ; Savitsky et al , 1995). At the meeting, several important developments were reported, including: an expansion of the substrate repertoire of the ATM kinase; the use of animal models to analyse the signalling pathways controlled by ATM and the functional consequences of disrupting these pathways; new insights into cell‐cycle control and the maintenance of genome stability; the influence of modifier genes on ATM function; and approaches for correcting the progressive neurodegeneration that is a part of this syndrome. Ataxia‐telangiectasia is an autosomal recessive disorder characterized by neurodegeneration, immunodeficiency, hypogonadism and susceptibility to cancer. At the cellular level, it is marked by genomic instability, which is due to a defective response to double‐stranded breaks (DSBs) in DNA. This is manifested by hypersensitivity to ionizing radiation (IR) and radiomimetic compounds, and by a decreased ability to activate the DNA‐damage‐response network, which includes the cell‐cycle checkpoints (Lavin & Shiloh, 1997; Chun & Gatti, 2004). The protein product of the ATM gene is present in the nucleus as an inactive dimer or oligomer, and is activated in response to DSBs in a process that involves autophosphorylation on serine (Ser) 1,981. This causes a dissociation of the dimer to form active monomeric forms, which are able to initiate the phosphorylation of many intermediates, such as p53 and the checkpoint kinase Chk2, which are involved in DNA repair and cell‐cycle control (Bakkenist & Kastan, 2003). However, ATM is not solely responsible for initiating this … [1]: /embed/graphic-1.gif

[1]  F. Collins,et al.  The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. , 1995, Human molecular genetics.

[2]  E. Boder Ataxia-telangiectasia: an overview. , 1985, Kroc Foundation series.

[3]  J. Nadeau Modifier genes and protective alleles in humans and mice. , 2003, Current opinion in genetics & development.

[4]  N. Gueven,et al.  ATP Activates Ataxia-Telangiectasia Mutated (ATM) in Vitro , 2003, The Journal of Biological Chemistry.

[5]  M. Gatei,et al.  Role for ATM in DNA damage-induced phosphorylation of BRCA1. , 2000, Cancer research.

[6]  P. Jeggo,et al.  Harmonising the response to DSBs: a new string in the ATM bow. , 2005, DNA repair.

[7]  M. Eguchi,et al.  Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia. , 1998, Cancer research.

[8]  John R Yates,et al.  The hMre11/hRad50 Protein Complex and Nijmegen Breakage Syndrome: Linkage of Double-Strand Break Repair to the Cellular DNA Damage Response , 1998, Cell.

[9]  T. Stankovic,et al.  The DNA Double-Strand Break Repair Gene hMRE11 Is Mutated in Individuals with an Ataxia-Telangiectasia-like Disorder , 1999, Cell.

[10]  Y. Shiloh,et al.  The genetic defect in ataxia-telangiectasia. , 1997, Annual review of immunology.

[11]  R. Gatti,et al.  Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Kastan,et al.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.

[13]  R. Gatti,et al.  Ataxia-telangiectasia, an evolving phenotype. , 2004, DNA repair.

[14]  K. Herrup,et al.  Loss of Neuronal Cell Cycle Control in Ataxia-Telangiectasia: A Unified Disease Mechanism , 2005, The Journal of Neuroscience.

[15]  Ji-Hoon Lee,et al.  ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex , 2005, Science.